Neuromuscular Flashcards

(66 cards)

1
Q

Upper Motor Neurons

A

Cerebral cortex → ventral motor horn
Direct, influence, & modify reflex arcs
Form synapses w/ interneurons & lower motor neurons before projecting to periphery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Corticospinal Tract

A

Motor transmission
Receives information from sensory cortex
AP to 1° motor neuron
Synapses w/ 2° efferent motor neuron
Decussates at medulla & travels down the spinal cord via the anterolateral tract
2° motor nerve synapses w/ 3° efferent motor neuron at ventral horn
3° (lower motor neuron) projects down to the skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Corticobulbar Tract

A

Cranial nerves
Bilaterally III, IV, VI, IX, X, XI
Unilateral facial VII & hypoglossal XII
Involved in precise motor movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lower Motor Neurons

A

Neurons located in brain stem & spinal cord
Direct influence on muscles
Send axons into PNS to synapse one & control skeletal muscle cells
Lower motor neurons that pass through the spinal nerves 1° control limb & trunk muscles
Pass through cranial nerves 1° control the head & neck skeletal muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NMJ

A

Neuromuscular junction
AP initiates synaptic transmission
Na+ channels depolarize the axon terminal membrane
Depolarization causes VGCa2+ channels to open
ACh diffuses across the synaptic cleft & binds to receptors on postsynaptic membrane
Depolarizes post-synaptic AP
ACh uptake to resynthesize/recycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Upper Motor Lesions

A
Motor cortex
Muscle groups are affected
 Mild weakness
Minimal diffuse muscle atrophy
No fasciculations
↑muscle stretch reflex
Hypertonia & spasticity
Pathological reflexes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lower Motor Lesions

A
Ventral horn (spinal cord) & motor nuclei (brainstem)
Individual muscles affected
Mild weakness
Severe muscle atrophy
Fasciculations
↓muscle stretch reflex
Hypotonia & flaccidity
- Babinski sign
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Upper Motor Neuron Disorders

A
Cerebral palsy
Multiple sclerosis
CVA
Parkinson's
Huntington's
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cerebral Palsy

A

Non-progressive disorder caused by injury or abnormal development in the immature brain
Before, during, or after birth up to 1yo
Damage or defects in the corticospinal pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CP S/S

A
Muscle weakness
Loss fine motor control
Impaired speech
Drooling
Exaggerated deep tendon reflexes
Spasticity
Extremity rigidity
Scoliosis, contractures, joint dislocation
Vision or hearing impairment
Swallowing problems
Seizures
Intellectual disability
Reflux disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CP Treatment

A
No cure
↑ADLs
Surgery (ortho, dental, general, ophthalmology, ENT)
- Dorsal rhizotomy
- Antireflux operation
- Intrathecal baclofen pump
Botulinum toxin
PT/OT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CP Anesthetic Considerations

A
Hold preop sedative
Caution w/ opioids
Difficult vascular access
Airway concerns d/t dentition, secretions, TMJ, ankylosis, & contractures
Potential RSI
Succinylcholine does not ↑K+ release
Cautious NDMR admin
↓MAC 20-30%
Prone to bleeding, hypothermia, & intravascular depletion
Slow emergence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Multiple Sclerosis

A

Autoimmune disease characterized by combination demyelination, inflammation, & CNS axonal damage
Peripheral nerves not affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MS S/S

A
Parethesias (face, arms, fingers, legs)
Muscle weakness/fatigue
Painful muscle spasms
Visual problems (optic neuritis & diplopia)
Autonomic instability
Bulbar muscle dysfunction
Cognitive dysfunction (advanced MS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MS Treatment

A
↓spasticity, tremors, bladder spasms
Diazepam
Dantrolene
Baclofen
Glucocorticoids
Immunosuppressants
CD20 monoclonal antibody - interferon B1a of glatiramer acetate

S/S exacerbated by stress, ↑body temp, infection, hyponatremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MS Anesthetic Considerations

A
AVOID SUCCINYLCHOLINE
Caution w/ NDMR admin
Avoid surgery during flare
Avoid spinal block
Epidurals safe
Aspiration risk
↑risk DVT
Stress-dose steroids
Exaggerated hypotensive effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cerebrovascular Accident

A

Stroke characterized by sudden neurologic deficits resulting from ischemia 88% or hemorrhage 12%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CVA S/S

A

Anterior cerebral artery - contralateral leg weakness
Middle cerebral artery - contralateral hemiparesis & sensory deficit (face/arms > legs), aphasia, contralateral visual field defect
Posterior cerebral artery - contralateral visual field defect & hemiparesis
Penetrating arteries - contralateral hemiparesis & contralateral hemisensory deficits
Basilar artery - oculomotor deficits and/or ataxia & crossed sensory & motor deficits
Vertebral artery - lower cranial nerve deficits & ataxia w/ crossed sensory deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CVA Treatment

A

Aspirin
TXA (IV admin or VIR direct infusion)
Surgery (crani/cerebellar resection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CVA Anesthetic Considerations

A

Aspiration & DVT risk
Maintain blood glucose
Blood pressure maintenance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Parkinson’s Disease

A

Neurodegenerative disorder
Unknown cause
Loss dopaminergic fibers in the basal ganglia
Regional dopamine concentrations are also depleted
Results in diminished neuron inhibition controlling the extrapyramidal motor system & unopposed ACh stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Parkinson’s S/S

A

Skeletal muscle rigidity (pill-rolling) - more prominent during rest & disappears during voluntary movement
Rigidity
Akinesia - loss voluntary movement
Diaphragmatic spasms
Dementia
Depression
Facial immobility (infrequent blinking & paucity emotional expressions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Parkinson’s Treatment

A
Levidopa - dopamine precursor
Carbidopa - peripheral dopa decarboxylase inhibitor
Amantadine 
Selegline & Rasgiline
Rpinirole - dopamine agonist
Entacapone - COMT inhibitor
Donepezil & Taurine - AChEi
Amatadine - antiviral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Parkinson’s Anesthetic Considerations

A
Continue Levidopa therapy
Aspiration/airway risk
Hypertension
Post-extubation laryngospasm
Avoid benzodiazepines
Ideal volatile agent = Sevoflurane
NDMB less effective
Use Sugammadex
Avoid indirect-acting NT releaser (Ephedrine)
Hypotension & cardiac dysrrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Huntington's Disease
DNS degenerative disease characterized by marked caudate nucleus atrophy & putamen & globus pallidus to lesser degree Autosomal dominant
26
Huntington's S/S
Progressive dementia Chorea (involuntary jerking or writhing movement) Tremors Rigidity & contractures Depression, aggressive outburst, mood swings Difficulty w/ speech & swallowing
27
Huntington's Treatment
Treat the choreiform movements Antidepressants (Haldol) Physical, occupational, & speech therapy
28
Huntington's Anesthetic Considerations
``` Aspiration risk → RSI Prolonged response to Succinylcholine Sensitive to NDMR Avoid anticholinergics & Reglan Glycopyrrolate > Atropine ```
29
Lower Motor Neurons Disorders
``` Myasthenia gravis Lambert-Eaton Muscular dystrophy Myotonic dystrophy Mitochondrial disorders Guillain-Barre Spinal muscular atrophy ```
30
Myasthenia Gravis
Autoimmune destruction IgG antibodies against nAChR Inactivation postsynaptic ACh receptors at NMJ ↓receptors & function degradation complement-mediated damage to postsynaptic end plate
31
MG S/S
``` Diploplia & ptosis Fluctuating fatigue & weakness that improves after rest Mouth & throat muscle weakness Dyspnea w/ exertion Proximal muscle weakness ```
32
MG Treatment
``` Cholinesterase inhibitor (Pyridostigmine) Plasmapheresis Corticosteroids Immunosuppressants & immunoglobins Thymectomy ``` S/S exacerbated by pregnancy, infection, electrolyte imbalance, surgical & psychological stress, aminoglycoside antibiotics
33
MG Anesthetic Considerations
``` Aspiration risk Sensitive to NDMR Regional preferred (amide LAs) Avoid block > mid thoracic or interscalene or supraclavicular block d/t phrenic nerve paralysis RESISTANT to Succinylcholine 2mg/kg DOA ↑5-10min ```
34
Lambert-Eaton
Pre-synaptic defect Antibodies attach to voltage-gated Ca2+ channels on the nerve terminal ↓ACh release at the motor end plate Affects males > females
35
LEMS S/S
Proximal muscles 1° affected Weakness generally worse in the morning & improves throughout the day Respiratory & diaphragm muscles become weak ANS dysfunction - Orthostatic hypotension - Delayed gastric motility - Urinary retention
36
LEMS Treatment
``` 3,4 DAP Guanidine hydrochloride Corticosteroids Immunosuppressants Plasmapheresis ```
37
LEMS Anesthetic Considerations
Sensitive to Succinylcholine & NDMR Inadequate reversal w/ AChE High risk postop respiratory failure 60% small cell carcinoma
38
Duchenne Muscular Dystrophy
``` X-linked recessive disorder Results from abnormal protein dystrophin production Affects males > females Presents between 3-5yo Rarely live past 30yrs ```
39
Duchenne MD S/S
Symmetric proximal muscle weakness manifested as gait disturbance "Gower sign" Fatty infiltration typically causes muscle enlargement (particularly the calves) Kyphoscoliosis Respiratory muscle weakness Cardiac muscle degeneration Impaired GI hypo-motility, airway reflexes, &cardiac conduction Cognitive impairment Pulmonary HTN
40
Becker Muscular Dystrophy
X-linked recessive disorder Partial dystrophin Less common than Duchenne
41
Becker MD S/S
``` Present later in life (adolescence) Disease progresses more slowly Less severe Intellectual disability less common Proximal muscle weakness Prominent calf pseudohypertrophy Cardiac muscle degeneration Death r/t respiratory complications ```
42
MD Diagnosis
Genetic testing ↑CK levels Muscle biopsy (rare)
43
MD Treatment
``` Surgery Physical therapy Steroids delay disease progression Biphosphates Mystatin inhibitors Gene modification Protease inhibitors Stem cell infusions ```
44
MD Anesthetic Considerations
Pre-anesthesia testing PFTs, echo, EEG, sleep apnea study Avoid Succinylcholine & volatile anesthetics Malignant hyperthermia syndrome characterized by rhabdomyolysis & hyperkalemia Avoid preop w/ benzodiazepines & opioids Positioning complications d/t kyphoscoliosis Sensitive to NDMR - prolonged DOA Local & regional anesthesia preferable Aspiration risk
45
Myotonic Dystrophy
Hereditary skeletal muscle degenerative disease Results in dysfunctional Ca2+ sequestration by SR Na+ & Cl¯ channel dysfunction
46
Myotonic Dystrophy S/S
Weakness - facial, thoracic, intercostal, diaphragm, sternocleidomastoid, & distal limb Inability to release/relax hand grip (myotonia) Cardiomyopathy Conduction defects 1st degree AV block Dysphagia & slowed gastric emptying Endocrine dysfunction Central sleep apnea Ptosis Males (triad) - frontal balding, cataracts, & testicular atrophy
47
Myotonic Dystrophy Treatment
``` Procainamide Phenytoin Mexiletine Baclofen Dantrolene Carbamazepine Cardiac pacemaker ```
48
Myotonic Dystrophy Anesthetic Considerations
Avoid Succinylcholine Aspiration risk Volatile anesthetics may produce exaggerated myocardial depression High volatile anesthetic concentrations potential to abolish myotonia Questionable d/t association w/ MH Anesthesia & surgery could aggravate cardiac conduction problems via ↑vagal tone Neostigmine & Physostigmine aggravate myotonia Sensitive to respiratory depressant Maintain normothermia & avoid shivering PFTs & EKG Transthoracic pacing readily available
49
Mitochondrial Disorder
Heterogenous groups Skeletal muscle energy metabolism disorders Mitochondria produce energy required by skeletal muscle cells through the oxidation-reduction reactions of the electron transport chain & oxidative phosphorylation → ADP
50
Mitochondrial Disorder S/S
Abnormal fatigue w/ sustained exercise Skeletal muscle pain & progressive weakness Hearing loss & impaired vision Balance & coordination problems Seizures Learning deficits Organ problems - heart, liver, kidney, brain
51
Mitochondrial Disorder Treatment
``` Symptomatic Admin metabolites & cofactors Sodium bicarbonate Dichloroacetate Ketogenic diet ```
52
Mitochondrial Disorder Anesthetic Considerations
``` Prone to acidosis & dehydration Lactate level (avoid LR) Avoid continuous infusion Propofol Avoid Succinylcholine Maintain normothermia Use NDMR & LAs w/ caution Avoid Bupivacaine Avoid prolonged tourniquets ```
53
Guillain-Barre
Immunologic assault on myelin in the peripheral nerves particularly lower motor neurons AP unable to be conducted Motor endplate does not receive the incoming signal Upward progression 2wks Full recovery 4wks w/ some permanent paralysis remaining
54
Guillain-Barre S/S
``` Flaccid paralysis Begins in distal extremities & ascends bilaterally Intercostal muscle weakness Facial & pharyngeal weakness Sensory deficits Autonomic dysfunction common Cognition intact ```
55
Guillain-Barre Treatment
Plasmapheresis IVIG Steroids not useful
56
Guillain-Barre Anesthetic Considerations
``` Avoid Succinylcholine NDMR sensitivity ↑DVT risk Aspiration risk Exaggerated response to indirect sympathomimetics (A-line) Assess Na+ levels Slow position changes Avoid barbiturates → CV depression (autonomic dysfunction) Postop ventilation ```
57
Spinal Muscular Atrophy
Deletions or mutations in survival motor neuron gene on chromosome 5q13 SMN gene involved in RNA complex formation & trafficking out nucleus Loss SMN function promotes apoptosis lower motor neurons - affects anterior spinal cord horn
58
SMA Type I
``` Most severe Infantile spinal muscular atrophy Autosomal recessive disorder Manifests w/in 3mos Rapidly progressive leading to death from respiratory complications usually by age 3 ``` Difficulty sucking, swallowing, breathing, atrophy & fasciculation in tongue & limb muscles
59
SMA Type II
Autosomal recessive inheritance Begins 6mos-1yo Progressive more slowly than infantile form Able to survive into adulthood
60
SMA Type III
Juvenile form Develops after age 2 Weakness proximal limb muscles w/ relative sparing bulbar muscles (cranial nerves)
61
SMA Treatment
``` Spinraza Zolgensma 2019 Evrysdi 2020 PT Surgery Antibiotics ```
62
SMA Anesthetic Considerations
Pulmonary consultation Difficult intubation d/t secretions, muscle weakness, contractures, & aspiration risk Avoid Succinylcholine Varying sensitivity to NDMR (longer DOA) Regional controversial - neuraxial difficult/unreliable Cautious w/ opioids Postop respiratory support
63
Amyotrophic Lateral Sclerosis
Mixed motor neuron disease - upper & lower motor Rapidly progressive motor neuron degeneration in corticospinal tract (1° descending upper motor neurons) & lower motor neurons in anterior spinal cord gray matter Astrocytic gliosis replaces the affected motor neurons
64
ALS S/S
``` Spasticity Hyperreflexia & loss coordination Muscle weakness Fasciculations Atrophy often begins in hands Orthostatic hypotension Resting tachycardia Sensation remains intact Cognition WNL Bladder & bowel function not typically affected ```
65
ALS Treatment
``` Riluzole (NDMA receptor antagonist) - Only drug that reduces mortality Edaravone ↓ADLs decline Spasmolytics Analgesics ```
66
ALS Anesthetic Considerations
``` Avoid Succinylcholine Hyperkalemia risk ↑NDMR sensitivity Aspiration risk Consider postop mechanical ventilation ↑sensitivity to respiratory depressants Autonomic dysfunction w/ hemodynamic instability risk (A-line) Avoid spinal anesthesia d/t demyelination Induction → PEA ```